Skip to main content
logo
NurExone Biologic Inc. (TSXV:NRX)
Canada flag Canada · Delayed Price · Currency is CAD
0.5400
+0.0450 (9.09%)
Aug 28, 2026, 3:59 PM EST

NurExone Biologic Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
5260441417-
Market Cap Growth
-22.98%36.16%208.80%-14.84%--
Enterprise Value
5059411312-
Last Close Price
0.540.660.620.290.39-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
18.6315.8317.3557.035.89-
P/TBV Ratio
18.6315.8317.3557.035.89-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.040.020.110.020.89
Net Debt / Equity Ratio
-0.72-0.74-0.38-2.76-1.15-0.99
Net Debt / EBITDA Ratio
0.230.330.140.140.44-
Net Debt / FCF Ratio
0.300.450.120.170.620.95
Quick Ratio
2.182.252.080.344.171.67
Current Ratio
2.232.634.111.044.461.74
Return on Equity (ROE)
-390.11%-282.54%-517.23%-318.51%-499.17%-
Return on Assets (ROA)
-150.84%-121.15%-135.79%-92.09%-123.02%-
Return on Capital Employed (ROCE)
-267.70%-204.40%-245.20%-1395.80%-252.90%-142.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-17.35%-14.63%-16.51%-33.76%-66.15%-
FCF Yield
-12.83%-10.46%-18.13%-28.40%-31.58%-
Buyback Yield / Dilution
-21.07%-22.31%-46.27%-18.52%-129.35%-